Recent aspects of drug-induced or toxic interstitial nephropathies;Nephropathies interstitielles d'origine medicamenteuse ou toxique

Presse Medicale

Volumn 26, Issue 10, 1997, Pages 477-484

  Fillastre, J P ^a   Legallicier, B ^a   Godin, M ^a   Le Roy, F ^a  

^a ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; ALPHA INTERFERON; ANTIBIOTIC AGENT; ANTIVIRUS AGENT; CIMETIDINE; COTRIMOXAZOLE; FENOPROFEN; HERBACEOUS AGENT; MESALAZINE; METICILLIN; NONSTEROID ANTIINFLAMMATORY AGENT; OCHRATOXIN; OMEPRAZOLE; PENICILLIN DERIVATIVE; PHENINDIONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN;

COLLAGEN SYNTHESIS; EXTRACELLULAR MATRIX; HUMAN; INTERSTITIAL NEPHRITIS; NEPHROTOXICITY; PATHOPHYSIOLOGY; REVIEW; ACUTE DISEASE; CHEMICALLY INDUCED DISORDER; CHRONIC DISEASE; IATROGENIC DISEASE; MEDICINAL PLANT;

ACUTE DISEASE; CHRONIC DISEASE; HUMANS; IATROGENIC DISEASE; NEPHRITIS, INTERSTITIAL; PLANTS, MEDICINAL;

EID: 0030933803     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Lemley KV, Kriz W. Anatomy of the renal interstitium. Kidney Int 1991 ; 39:370-81.
2. Droz D, Ronco P. Description du parenchyme rénal normal : relations structure/fonction. In: La biopsie rénale, Droz D, Lantz B eds. Editions INSERM, Paris 1996:37-63.
3. Cameron JS. Aspects immunologiques des néphrites tubulo-interstitielles primitives et secondaires. In: Actualités néphrologiques de l'hôpital Necker, Funck-Brentano JL, Bach JF, Grünfeld JP eds. Médecine-Sciences Flammarion 1988:223-61.
4. Kleinknecht D. Les néphrites interstitielles aiguës immuno-allergiques d'origine médicamenteuses. In: Actualités néphrologiques de l'hôpital Necker, Hamburger J, Crosnier J, Funck-Brentano JL eds. Flammarion, Paris, 1969:155-93.
5. World MJ, Stvens PE, Ashton MA, Rainford DJ. Mésalazine-associated interstitial nephritis. Nephrol Dial Transplant 1996 ; 11:614-21.
6. Vanherweghem JL, Depierreux M, Tielemans C et al. Rapidly progressive interstitial renal fibrosis in young women : association with slimming regimen including chinese herbs. Lancet 1993 ; 341:387-91.
7. Depierreux M, Van Damme B, Vanden Houte K, Vanherweghem JL Pathologic aspects of a newly described nephropathy related to the prolonged use of chinese herbs. Am J Kidney Dis 1994 ; 24:172-80.
8. Matsusaka T, Fujii M, Nakano T et al. Germanium-induced nephropathy : report of two cases and review of the literature. Clin Nephrol 1988 ; 30:341-5.
9. Godin M, Fillastre JP, Simon P, François A, Le Roy F, Morin JP. L'ochrotaxine est-elle néphrotoxique chez l'homme. In: Actualités néphrologiques Jean Hamburger, Funck-Brentano JL, Bach JF, Kreis H, Grünfeld JP eds. Médecine-Sciences Flammarion, Paris 1996:224-50.
10. Spoendlin M, Moch H, Brunner F, et al. Karyomegalic interstitial nephritis further support for a distinct entity and evidence for a genetic defect. Am J Kidney Dis 1995 ; 25:242-52.
11. Steblay RW, Rudofsky U. Renal tubular disease and autoantibodies against tubular basement membrane induced in guinea pigs. J Immunol 1971 ; 107:589-94.
12. Druet Ph. Physiopathologie des néphropathies interstitielles expérimentales immunes. In: Séminaires d'Uronéphrologie. Chatelain C, Jacobs C eds. Masson, Paris 1988:41-8.
13. Bolton WK, Benton FR, Sturgill BC. Autoimmune glomerulotubular nephropathy in mice. Clin Exp Immunol 1978 ; 33:463-73.
14. Baldwin DS, Levine BB, Mc Cluskey RT, Gallo GR. Renal failure and interstitial nephritis due to penicillin and methicillin. N Engl J Med 1968 ; 279:1245-52.
15. Grussendorf M, Andrassy K, Waldherr, Ritz E. Systemic hypersensitivity to allopurinol with acute interstitial nephritis. Am J Nephrol 1981 ; 1:105-9.
16. Klassen J, Mc Cluskey RT, Milgrom F. Nonglomerular renal disease produced in rabbits by immunization with homologous kidney. Am J Pathol 1971 ; 63:333-58.
17. Brentjens J, O' Connell DW, Pawlowski IB, Andres SA. Extraglomerular lesions associated with deposition of circulating antigen-antibody complexes in kidneys of rabbits with chronic serum sickness. Clin Immunol Immunopathol 1974 ; 3:112-26.
18. Rudofsky UH, Dilwith RI, Tung KSK. Susceptibility differences of inbred mice to induction of autoimmune renal tubulo-interstitial lesions. Lab Invest 1980 ; 43:463-70.
19. Zakheim B, Mc Cafferty E, Phillips SM, Clayman M, Neilson EG. Murine interstitial nephritis II. The adoptive transfer of disease with immune T lymphocytes produces a phenotipically complex interstitial lesion. J Immunol 1984 ; 133:234-9.
20. Kelly CJ, Korngold R, Mann R, Clayman M, Haverty T, Neilson EG. Spontaneous interstitial nephritis in kd/kd mice. J Immunol 1986 ; 136:526-31.
21. Bohle A, Mackensen-Haen S, Gise H et al. The consequences of tubulo-interstitial changes for renal function in glomerulopathies. Pathol Res Pract 1990 ; 186:135-44.
22. Müller GA, Schettler V, Müller CA, Structz F. Prevention of progression of renal fibrosis : how far are we. Kidney Int 1996 ; 49 (suppl. 54):S75-82.
23. Striker G, Schainuck LI, Cutler RE, Benditt EP. Structural-functionnal correlations in renal disease. Part I : a method for assaying and classifying histopathologic changes in renal disease. Hum Pathol 1970 ; 1:615-30.
24. Müller GA, Markovic-Lipovski J, Rodemann HP. The progression of renal diseases : on the pathogenesis of renal interstitial fibrosis. Klin Wochenschr 1991 ; 69:576-86.
25. Nathan CF. Secretory products of macrophages. J Clin Invest 1987 ; 79:319-26.
26. Klahr S. Interstitial macrophages. Semin Nephrol 1993 ; 13:488-95.
27. Dennis M, Bisson D. Blockage of leucocyte function-associated antigen (LFA-1) in a murine model of lung inflammation. Am J Respir Cell Mol Biol 1994 ; 10:481-6.
28. Levitzki A. Tyrphostins : tyrosine kinase blockers as novel antiproliferative agents and dissectors of signal transduction. Faseb J 1992 ; 6:3275-82.
29. Clozel M, Breu V, Burri K et al. Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature 1993 ; 365:759-61.
30. Lonnemann G, Shapiro L, Engler-Blum C, Müller GA, Koch KM, Dinarello CA. Cytokines in human renal interstitial fibrosis I. IL1 is an autocrine growth factor for cultured fibrosis derived kidney fibroblast. Kidney Int 1995 ; 47:837-44.
31. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature 1990 ; 346:371-4.
32. Yamamoto T, Noble NA, Miller DE, Border WA Sustained expression of TGF-β, underlies development of progressive kidney fibrosis. Kidney Int 1994 ; 45:916-27.
33. Bachern MG, Meyer D, Melchior R, Sell KM, Gressner AM. Activation of rat liver perisinusoidal by transforming growth factors derived from myofibroblast-like cells. A potential mechanism of self perpetuation in liver fibrogenesis. J Clin Invest 1992 ; 89:19-27.
34. Khalil N, Bereznay O, Sporn M, Geenburg AH. Macrophage production of transforming growth factor β and fibroblast collagen synthesis in chronic pulmonary inflammation. J Exp Med 1991 ; 170:727-37.
35. Border WA, Noble NA, Yamamoto T et al. Natural inhibitor of transforming growth factor β protects against scarring in experimental kidney disease. Nature 1992 ; 360:361-4.
36. Giri SN, Hyde DM, Hollinger MA. Effect of antibody to transforming growth factor b on bleomycin induced accumulation of lung collagen in mice. Thorax 1993 ; 48:959-66.
37. Duncan Mr, Berman B. γ interferon is the lymphokine and β interferon the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation. J Exp Med 1985 ; 162:516-27.
38. Varga J, Olsen A, Herhal J, Constantine G, Rosenbloom J, Jiminez SA. Interferon γ reverses the stimulation of collagen but not fibronectin gene expression by transforming growth factor b in normal human fibroblasts. Eur J Clin Invest 1990 ; 20:487-93.
39. Franklin TJ. Opportunities for the discovery of novel therapies for fibrotic diseases. Exp Nephrol 1995 ; 3:143-7.
40. Alexander CM, Werb Z. Proteinases and extracellular matrix remodeling. Curr Opin Cell Biol 1989 ; 1:974-82.
41. Jones CL, Feondo J, Kelynack K, Forbes J, Walker R, Becker G. Tissue inhibitor of the metalloproteinases and renal extracellular matrix accumulation. Exp Nephrol 1995 ; 3:80-6.
42. Jones CL, Buch S, Post M, Culloch LM, Liu E, Eddy AA. Renal extracellular matrix accumulation in acute puromycin aminonucleoside nephrosis in rats. Am J Pathol 1992 ; 141:1381-96.
43. Unemori EN, Beck LS, Lee WP et al. Human relaxin decreases collagen accumulation in vivo in 2 rodent models of fibrosis. J Invest Dermatol 1993 ; 101:280-5.
44. Bickel M, Baader E, Brocks DG. Beneficial effects of inhibitors of prolyl 4 hydroxylase Ccl4 - induced fibrosis of the liver in rats. J hepatol 1991 ; 13 (suppl. 3):S26-34.
45. Arthur MJP. Pathogenesis, experimental manipulation and treatment of liver fibrosis. Exp Nephrol 1995 ; 3:90-5.